The coronavirus vaccine being developed by the University of Oxford and AstraZeneca could still be made available at a similar time to the other leading candidates, according to the head of Oxford’s vaccine trial. Andrew Pollard made his comments shortly after a peer-reviewed analysis of phase two trials, published Thursday, showed the Oxford-AstraZeneca shot triggered a robust immune response […]

